Clinical trial
Hepatitis C Treatment of Inmates
NCT00209898 · Haukeland University Hospital, Other · Terminated
Key facts
| NCT number | NCT00209898 |
|---|---|
| Title | Hepatitis C Treatment of Inmates |
| Official title | Hepatitis C Treatment of Inmates. A Randomized, Open-label Study Evaluating the Feasibility, Safety and Efficacy of Treatment With Peginterferon Alfa-2a in Combination With Ribavirin in Inmate Patients With Chronic Hepatitis C |
| Acronym | PEGPRI |
| Lead sponsor | Haukeland University Hospital, Other |
| Collaborators | Bergen Prison, Norwegian Correctional Service Hoffmann-La Roche Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C |
| Intervention type | Procedure |
| Interventions | Fast initiation procedure |
| Enrollment | 42 |
| Start date | Aug 1, 2003 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Sep 21, 2005 |
| Last update posted | Mar 20, 2015 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: